. . . . . . . . . . "a(SCHEM:\"NS 398\") -| a(SCHEM:Dinoprostone)" . "Approximately 61,000 statements." . "Copyright (c) 2011-2012, Selventa. All rights reserved." . "BEL Framework Large Corpus Document" . . "1.4" . "The elevated PGE2 production by metastatic cancer cells was due to COX-2 activity since dual COX-1/2 inhibitor indomethacin and selective COX-2 inhibitor NS-398 equally suppressed both basal and inducible (by IFN-gamma/LPS or Ca2+-ionophores) PGE2 accumulation." . . "Selventa" . . . . "2014-07-03T14:30:16.850+02:00"^^ . . .